Literature DB >> 24497154

"One-off" complete radiofrequency ablation for hepatocellular carcinoma in a "high-risk location" adjacent to the major bile duct and hepatic blood vessel.

Kai Jiang1, Wen-zhi Zhang, Yang Liu, Ming Su, Xiang-qian Zhao, Jia-hong Dong, Zhi-qiang Huang.   

Abstract

Radiofrequency ablation (RFA) is an effective, minimally invasive treatment option for unresectable hepatocellular carcinomas (HCCs) located in high-risk areas or for patients with poor hepatic functional reserve. However, for tumors adjacent to major bile ducts and hepatic blood vessels, complete ablation is difficult to achieve for fear of causing a postoperative bile leak, bilioma or bile duct stenosis. Therefore, RFA is often combined with multiple alcohol injections to eliminate residual tumor tissues in adjacent bile duct or blood vessels; however, the injections directly affect the efficacy and prognosis of RFA. This study reports three successful "one-off" cases of complete ablation of HCCs adjacent to major bile ducts and blood vessels in neighboring hepatic segments or hepatic lobes, highlighting both the efficacy and safety of RFA for HCC tumors in these high-risk locations.

Entities:  

Mesh:

Year:  2014        PMID: 24497154     DOI: 10.1007/s12013-014-9840-8

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  7 in total

1.  Prevention of major biliary complications by fusion imaging for thermal ablation of malignant liver tumors adjacent to the bile ducts: a preliminary comparative study.

Authors:  Jia Liu; Lu Li; Qingjing Zeng; Rongqin Zheng; Kai Li
Journal:  Abdom Radiol (NY)       Date:  2022-09-19

Review 2.  Laparoscopic thermoablation for hepatocellular carcinoma in patients with liver cirrhosis: an effective procedure for tricky tumors.

Authors:  Roberto Santambrogio; Matteo Barabino; Valentina D'Alessandro; Elisa Galfrascoli; Marco Antonio Zappa; Gaetano Piccolo; Massimo Zuin; Enrico Opocher
Journal:  Med Oncol       Date:  2020-03-19       Impact factor: 3.064

3.  Inhibitory effect of endostar on specific angiogenesis induced by human hepatocellular carcinoma.

Authors:  Qing Ye; Shukui Qin; Yanhong Liu; Jundong Feng; Qiong Wu; Wenshu Qu; Xiaojin Yin
Journal:  Gastroenterol Res Pract       Date:  2015-04-23       Impact factor: 2.260

4.  Improving Ablation Safety for Hepatocellular Carcinoma Proximal to the Hilar Bile Ducts by Ultrasound-MR Fusion Imaging: A Preliminary Comparative Study.

Authors:  Yujia You; Yinglin Long; Ronghua Yan; Liping Luo; Man Zhang; Lu Li; Qingjing Zeng; Kai Li; Rongqin Zheng; Erjiao Xu
Journal:  Front Oncol       Date:  2021-03-01       Impact factor: 6.244

5.  The development of a predictive risk model on post-ablation hemobilia: a multicenter matched case-control study.

Authors:  Bozhi Liu; Honglu Li; Jiang Guo; Youjia Duan; Changqing Li; Jinglong Chen; Jiasheng Zheng; Wei Li
Journal:  Br J Radiol       Date:  2020-12-22       Impact factor: 3.039

6.  Green-Synthesized Silver Nanoparticle-Assisted Radiofrequency Ablation for Improved Thermal Treatment Distribution.

Authors:  Zhannat Ashikbayeva; Arman Aitkulov; Timur Sh Atabaev; Wilfried Blanc; Vassilis J Inglezakis; Daniele Tosi
Journal:  Nanomaterials (Basel)       Date:  2022-01-27       Impact factor: 5.076

7.  Efficacy of Percutaneous Thermal Ablation Combined With Transarterial Embolization for Recurrent Hepatocellular Carcinoma After Hepatectomy and a Prognostic Nomogram to Predict Survival.

Authors:  Zhuhui Yuan; Yang Wang; Caixia Hu; Wenfeng Gao; Jiasheng Zheng; Wei Li
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.